glp-1 manjaro mounjaro®（GLP-1/GIP） Mounjaro, Zepbound: Generic GLP-1 Drugs

Using propensity matching, the researchers compared 2,894 patients taking a GLP-1 receptor agonist at baseline with 2,894 patients not taking one at baseline

doi: 10.2147/dmso.S312527 [DOI] [PMC free article] [PubMed] [Google Scholar] 85

Fasting during Wegovy and Zepbound is increasingly common, with patients often reporting easier fasting periods due to reduced hunger

What Should I Do If I Hit a Weight Loss Plateau on Tirzepatide

Many people find this the hardest step because the contrast with their previous level of control is stark

The impact on Medicare spending associated with expanded coverage of Wegovy will depend in part on how many Part D plans add coverage for it and the extent to which plans apply restrictions on use like prior authorization